Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

BTMDBTMD
Showing 8 of 11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in BIOTE CORP

Yes. Citadel Advisors holds 301,310 shares of BTMD (Biote), worth $569,476, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$569,476

Current Shares

301,310

Total Value Change

+$350,439

Total Shares Change

+262,056

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
301,310
-
$569,4760.0%$1.89
34
2026-Q1
Exited
0
-100.0%
$00.0%$2.11
0
2025-Q4
New
84,351
-
$219,3130.0%$2.62
35
2025-Q3
Exited
0
-100.0%
$00.0%$2.99
0
2025-Q2
Increased
33,749
+73.2%
$135,6710.0%$4.20
23
2025-Q1
New
19,481
-
$64,8720.0%$3.39
32
2024-Q4
Exited
0
-100.0%
$00.0%$5.91
0
2024-Q3
Decreased
39,254
-48.1%
$219,0370.0%$5.67
0

Other major holders of BTMD: Nuveen, LLC, BlackRock Finance, Inc., BlackRock, Inc., WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used